Correlation Between BioLife Sciences and Carl Zeiss

Can any of the company-specific risk be diversified away by investing in both BioLife Sciences and Carl Zeiss at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioLife Sciences and Carl Zeiss into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between BioLife Sciences and Carl Zeiss Meditec, you can compare the effects of market volatilities on BioLife Sciences and Carl Zeiss and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioLife Sciences with a short position of Carl Zeiss. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioLife Sciences and Carl Zeiss.

Diversification Opportunities for BioLife Sciences and Carl Zeiss

0.0

Correlation Coefficient

BioLife Sciences  Carl Zeiss

Pay attention - limited upside

The 3 months correlation between BioLife and Carl is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding BioLife Sciences and Carl Zeiss Meditec in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Carl Zeiss Meditec and BioLife Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioLife Sciences are associated (or correlated) with Carl Zeiss. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Carl Zeiss Meditec has no effect on the direction of BioLife Sciences i.e., BioLife Sciences and Carl Zeiss go up and down completely randomly.

Pair Corralation between BioLife Sciences and Carl Zeiss

Given the investment horizon of 90 days BioLife Sciences is expected to generate 25.86 times more return on investment than Carl Zeiss. However, BioLife Sciences is 25.86 times more volatile than Carl Zeiss Meditec. It trades about 0.1 of its potential returns per unit of risk. Carl Zeiss Meditec is currently generating about -0.05 per unit of risk. If you would invest  0.01  in BioLife Sciences on September 4, 2024 and sell it today you would earn a total of  0.00  from holding BioLife Sciences or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

BioLife Sciences  vs.  Carl Zeiss Meditec

BioLife Sciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days BioLife Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, BioLife Sciences is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Carl Zeiss Meditec

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Carl Zeiss Meditec has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with BioLife Sciences and Carl Zeiss

The main advantage of trading using opposite BioLife Sciences and Carl Zeiss positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioLife Sciences position performs unexpectedly, Carl Zeiss can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Carl Zeiss will offset losses from the drop in Carl Zeiss' long position.

The idea behind BioLife Sciences and Carl Zeiss Meditec pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.